Ads
related to: medtronic defibrillator pads
Search results
Results From The WOW.Com Content Network
Subcutaneous implantable cardioverter defibrillator, or S-ICD, is an implantable medical device for detecting and terminating ventricular tachycardia and ventricular fibrillation in patients at risk of sudden cardiac arrest. [1]
Illustration of Implantable Cardioverter Defibrillator (ICD) An implantable cardioverter-defibrillator (ICD) or automated implantable cardioverter defibrillator (AICD) is a device implantable inside the body, able to perform defibrillation, and depending on the type, cardioversion and pacing of the heart.
Medtronic operational headquarters in Fridley, Minnesota, a suburb of Minneapolis. Medtronic was founded in 1949 in Minneapolis by Earl Bakken and his brother-in-law, Palmer Hermundslie, as a medical equipment repair shop. [8] Bakken invented several medical technology devices that continue to be used around the world today. [citation needed]
In 2006, Medtronic announced a spin-off of Physio-Control, however the company was still owned by Medtronic at this time. [5] In 2008, shortly after the spin-off was launched, Physio-Control launched the Lifepak 15 Monitor/Defibrillator.
Despite being the companies first "LIFEPAK" branded defibrillator, it was named the Lifepak 33 due to the companies target weight of 33 pounds for the defibrillator. [ 7 ] In 1971, the Lifepak 911 was released with 12-lead ECG monitoring capability, with the Lifepak 2 being released the following year.
The pads are then attached to a monitor/defibrillator, a heart rate is selected, and current (measured in milliamps) is increased until electrical capture (characterized by a wide QRS complex with tall, broad T wave on the ECG) is obtained, with a corresponding pulse. Pacing artifact on the ECG and severe muscle twitching may make this ...
Ad
related to: medtronic defibrillator pads